Did you miss our latest Investment Forums / Demo Days?
Don’t worry, we’re planning many more in varying locations so we hope you’ll be able to join us at an event in the coming months.
Capital Cell organises these kinds of events on a regular basis, aiming to bring together promising biotech companies and early-stage company investors. Companies are given the chance to pitch their innovative ideas to a room full of investors and investor representatives, and discuss the investment opportunities in more detail as part of roundtable sessions and networking.
Here’s a quick update on what happened during the last couple of months:
At the end of March, just before the official launch of our UK equity investment platform, we held our first British Investment Forum / Demo Day, in London.
Check out their exciting projects and discover how to be part of them.
A project concerned with the natural vector control of mosquito-borne diseases, through non-GM sterile insect production and release.
A heated drug delivery system which enhances the delivery of existing and new drugs to improve efficacy in the treatment of a range of cancers.
A revolutionary solid cancer therapy based on a novel type of Antibody Drug Conjugates (ADC).
A market-ready medical device which helps preserve the health of veins via new, more accurate detection technology.
A bedside diagnostic device that accurately distinguishes healthy/benign biopsies in minutes.
Leukocyte Infusion Therapy (LIfT) is a stem cell derived immune-oncology cell therapy, suitable for all solid tumor types.
The evening ended with a roundtable session which proved to be a great opportunity for companies and investors to spend valuable time networking. Positive feedback showed that both entrepreneurs and investors enjoyed the chance to speak at length and share scientific and investment knowledge.
From London to Madrid.
On May 18th we organised our 5th Investment Forum, and our first in the Spanish capital city – Madrid. Again there were many high profile pitches and a fantastic audience of investors, entrepreneurs and a ‘crowd’ interested in becoming part of the Capital Cell crowdfunding network.
6 companies presented their investment opportunities. Vaxdyn’s campaign can already be found on the Spanish Capital Cell platform, and in the coming weeks many more companies will be joining them.
Currently developing “in vitro” tests, based on patient’s blood cell culture, which allow the optimisation and personalisation of immunological therapies for autoimmune diseases.
A technology that automatically standardises all the processes necessary for a safe administration of stem cell therapies to the patient.
PERSEI VIVARIUM / CLINICAAL
A Digital Health platform that makes it easier the management of pathology processes, across hospitals, making possible the use of this information for a variety of purposes such as research, indicators, big data.
Medical devices that connect to the mobile phone (mhealth) such as digital stethoscopes and a pre-diagnostic system for Idiopathic Pulmonary Fibrosis (IPF).
A wearable which is able to record and predict a epileptic seizure 1 minute before it actually occurs and monitor the user’s brain activity in order to generate clinical reports.
An innovative vaccine to tackle the problem of infections caused by antibiotic-resistant pathogens.
Additionally, TBIOM explained the success story of their Airmony crowdfunding campaign (an innovative medical device designed to help people with Sleep Apnea). The company shared their experience of working with Capital Cell and how they managed to overfund (125%), raising more than 180K €.
Once again, the evening ended with a valuable roundtable session, which fuelled many interesting discussions about the investment opportunities being presented.
We’re in the process of organising more Investment Forums / Demo Days in Girona, London and Manchester, so keep an eye out for our announcements, and get your free ticket to attend.